Sclerotic bodies beyond nephrogenic systemic fibrosis

Journal of Cutaneous Pathology

Volumn 40, Issue 9, 2013, Pages 812-817

  Bhawan, Jag ^a   Perez Chua, Tanya A ^a   Goldberg, Lynne ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

gadolinium; lollipop lesion; nephrogenic systemic fibrosis; osseous metaplasia; sclerotic bodies

Indexed keywords

GADOLINIUM;

CASE REPORT; CHEMICALLY INDUCED; COMPLICATION; DRUG EFFECTS; FIBROBLAST; HUMAN; KIDNEY FAILURE, CHRONIC; MALE; METABOLISM; NEPHROGENIC SYSTEMIC FIBROSIS; PATHOLOGY; RADIOGRAPHY; SKIN; TOXICITY; VERY ELDERLY; WOUND HEALING; ARTICLE; BONE METAPLASIA; CHEMICALLY INDUCED DISORDER; CHRONIC KIDNEY FAILURE; DRUG EFFECT; LOLLIPOP LESION; SCLEROTIC BODIES;

AGED, 80 AND OVER; FIBROBLASTS; GADOLINIUM; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; NEPHROGENIC FIBROSING DERMOPATHY; SKIN; WOUND HEALING;

GADOLINIUM; LOLLIPOP LESION; NEPHROGENIC SYSTEMIC FIBROSIS; OSSEOUS METAPLASIA; SCLEROTIC BODIES;

EID: 84883052054     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/cup.12187     Document Type: Article

References (19)

1. Cowper SE, Robin HS, Steinberg SM, Su LD, Gupta S, LeBoit PE,. Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet 2000; 356: 1000.
2. Cowper SE, Su LD, Bhawan J, Robin HS, LeBoit PE,. Nephrogenic fibrosing dermopathy. Am J Dermatopathol 2001; 23: 383.
3. Kucher C, Steere J, Elenitsas R, Siegel DL, Xu X,. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis with diaphragmatic involvement in a patient with respiratory failure. J Am Acad Dermatol 2006; 54: S31.
4. Wilford C, Fine JD, Boyd AS, Sanyal S, Abraham JL, Kantrow SM,. Nephrogenic systemic fibrosis: report of an additional case with granulomatous inflammation. Am J Dermatopathol 2010; 32: 71.
5. Igreja AC, Mesquita Kde C, Cowper SE, Costa IM,. Nephrogenic systemic fibrosis: concepts and perspectives. An Bras Dermatol 2012; 87: 597.
6. Bhawan J, Swick BL, Koff AB, Stone MS,. Sclerotic bodies in nephrogenic systemic fibrosis: a new histopathologic finding. J Cutan Pathol 2009; 36: 548.
7. Wiedemeyer K, Kutzner H, Abraham JL, et al. The evolution of osseous metaplasia in localized cutaneous nephrogenic systemic fibrosis: a case report. Am J Dermatopathol 2009; 31: 674.
8. Kartono F, Basile A, Roshdieh B, Schwimer C, Shitabata PK,. Findings of osseous sclerotic bodies: a unique sequence of cutaneous bone formation in nephrogenic systemic fibrosis. J Cutan Pathol 2011; 38: 286.
9. Ruiz-Genao DP, Pascual-Lopez MP, Fraga S, Aragüés M, Garcia-Diez A,. Osseous metaplasia in the setting of nephrogenic fibrosing dermopathy. J Cutan Pathol 2005; 32: 172.
10. Nagai Y, Hasegawa M, Shinmi K, et al. Nephrogenic systemic fibrosis with multiple calcification and osseous metaplasia. Acta Derm Venereol 2008; 88: 597.
11. Berk DR, Miller A, Scarlett D, Wippold FJ 2nd, Bayliss SJ, Lu D,. Osseous metaplasia late in the course of nephrogenic systemic fibrosis. Dermatol Online J 2010; 16: 3.
12. Deng A, Martin DB, Spillane A, et al. Nephrogenic systemic fibrosis with a spectrum of clinical and histopathological presentation: a disorder of aberrant dermal remodeling. J Cutan Pathol 2010; 37: 204.
13. Milless T, LaChance A, Moeckel G, Cowper S,. The lollipop lesion: its prevalence and potential diagnostic significance in nephrogenic systemic fibrosis [Abstract]. J Cutan Pathol 2011; 38: 85.
14. Grekin SJ, Holcomb MJ, Modi GM, Huttenback YT, Poythress EL, Diwan AH,. Lollipop lesions in nephrogenic systemic fibrosis mimicking a deep fungal infection. J Cutan Pathol 2012; 39: 981.
15. Elmholdt TR, Pedersen M, Jørgensen B, et al. Nephrogenic systemic fibrosis is found only among gadolinium-exposed patients with renal insufficiency: a case-control study from Denmark. Br J Dermatol 2011; 165: 828.
16. Pryor JG, Scott GA,. Nephrogenic systemic fibrosis: a clinicopathologic study of 6 cases. J Am Acad Dermatol 2007; 57: 902.
17. Do JG, Kim YB, Lee DG, Hwang JH,. A case of delayed onset nephrogenic systemic fibrosis after gadolinium based contrast injection. Ann Rehabil Med 2012; 36: 880.
18. Edward M, Quinn JA, Mukherjee S, et al. Gadodiamide contrast agent 'activates' fibroblasts: a possible cause of nephrogenic systemic fibrosis. J Pathol 2008; 214: 584.
19. MacNeil S, Bains S, Johnson C, et al. Gadolinium contrast agent associated stimulation of human fibroblast collagen production. Invest Radiol 2011; 46: 711.